CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise 10b5-1 | +45,000 | $29.81 | $1.3M | 48,200 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise 10b5-1 | +50,000 | $22.85 | $1.1M | 98,200 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Sale 10b5-1 | −14,001 | $72.66 | $1.0M | 84,199 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Sale 10b5-1 | −34,640 | $73.54 | $2.5M | 49,559 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Sale 10b5-1 | −37,044 | $74.55 | $2.8M | 12,515 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Sale 10b5-1 | −9,215 | $75.44 | $695K | 3,300 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Sale 10b5-1 | −100 | $76.04 | $8K | 3,200 |
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,000 | 0 | ||
| 2023-05-17 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 0 | ||
| 2023-05-03 | Selkoe Dennis J. Director | Option exercise 10b5-1 | +6,000 | $9.23 | $55K | 8,845 |
| 2023-05-03 | Selkoe Dennis J. Director | Option exercise 10b5-1 | +9,000 | $23.97 | $216K | 17,845 |
| 2023-05-03 | Selkoe Dennis J. Director | Sale 10b5-1 | −15,000 | $57.00 | $855K | 2,845 |
| 2023-05-03 | Selkoe Dennis J. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | ||
| 2023-05-03 | Selkoe Dennis J. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,000 | 6,000 | ||
| 2023-04-26 | Malecek Michael J Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $10.27 | $51K | 5,000 |
| 2023-04-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −4,680 | $53.40 | $250K | 320 |
| 2023-04-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −320 | $54.25 | $17K | 0 |
| 2023-04-26 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 115,000 | ||
| 2023-04-19 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $15.04 | $75K | 5,000 |
| 2023-04-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,917 | $52.64 | $154K | 2,083 |
Page 15 of 28 · 555 trades